GHET1 and cancer: A fixed-effect model was used for mild heterogeneity across included studies (I2 = 47%, P=0.08), and results showed high lncRNA GHET1 expression was significantly associated with shorter OS than low lncRNA GHET1 expression in cancers (HR = 2.59, 95% CI = 1.93–3.47, P<0.01).